Is Hair Loss a Common Symptom of Lung Cancer?

Hair loss is not typically caused by lung cancer itself; it most often happens as a side effect of certain treatments, especially some chemotherapy drugs. ^[1] Targeted therapies for lung cancer generally do not cause hair loss, and immunotherapy rarely does. ^{[2] [3]}

---

Why Hair Loss Happens

• Chemotherapy effect on fast‑growing cells
  Chemotherapy targets fast-dividing cells, which includes hair follicles, so some lung cancer regimens can cause temporary hair loss (alopecia). ^[1] The timing often starts about 2–3 weeks after the first treatment, and hair may fall from the scalp and body. ^{[4] [5] [6]}

  • Docetaxel (a taxane sometimes used in non‑small cell lung cancer) is known to cause chemotherapy‑induced alopecia; rarely, hair loss can be prolonged or persistent after treatment. [PM7]

• Targeted therapy and immunotherapy
  Most lung cancer targeted drugs do not typically cause hair loss. ^[2] Alopecia with immunotherapy is uncommon (around 1–2%), though various skin reactions can occur. ^[3]

• EGFR inhibitors and hair/scalp changes
  EGFR‑targeted therapies can lead to dermatologic side effects including hair texture changes, nonscarring alopecia, or rare scarring alopecia (folliculitis decalvans). [PM26] Rare case series have reported scarring alopecia with EGFR inhibitors (e.g., afatinib). [PM24]

---

Is Hair Loss Common in Lung Cancer?

• From the cancer itself: Hair loss is not a typical direct symptom of lung cancer. ^[1]
• From treatment: Hair loss can be common with certain chemotherapy regimens used for lung cancer, but it depends on the specific drugs and doses. ^[4] Hair loss risk varies widely by regimen; some combinations are more likely to cause complete hair loss. ^{[7] [5] [6]}

---

What Hair Loss Looks Like and When It Starts

• Onset and extent
  Hair shedding usually begins 2 to 3 weeks after the first chemotherapy session and may affect scalp and body hair. ^{[4] [5] [6]}
  Scalp may feel tender during active shedding. ^{[4] [5] [6]}
  With certain regimens, complete baldness can occur, typically temporarily. ^{[7] [5] [6]}

---

Prevention Strategies

• Scalp cooling (“cold caps”)
  Wearing a cold cap before, during, and after chemotherapy can reduce blood flow to scalp follicles, lowering drug uptake and reducing hair loss. ^{[8] [9]}
  Effectiveness varies by chemotherapy type, dose, and regimen; results range roughly from limited benefit to substantial hair preservation. ^{[8] [10]}
  Scalp cooling is recommended with regimens that carry higher alopecia risk and may benefit some people with lung cancer receiving such regimens. ^[11]

• Planning ahead
  Discuss hair loss risk with your oncology team based on your exact regimen; some lung cancer treatments are unlikely to cause hair loss, so preventive measures may not be necessary. ^{[2] [1]}

---

Management During Treatment

• Gentle hair and scalp care
  Use gentle shampoo and a soft brush; avoid harsh products like dyes, bleaches, perms, and heavy heat styling; protect your scalp from cold and sun. ^{[4] [5] [6]}
  Simple routine care (washing every 2–4 days, fragrance‑free shampoo, careful brushing) helps comfort and scalp health. ^[12]

• Wigs and head coverings
  If you prefer a wig, consider selecting one before major hair loss so it matches your style; hats, scarves, and other coverings are helpful for warmth and sun protection. ^[13]

• Emotional support and resources
  Appearance support programs and oncodermatology services can help with practical tips and coping strategies. ^{[14] [15]}

---

After Treatment: Regrowth and Persistent Alopecia

• Typical regrowth
  Most chemotherapy‑related hair loss is temporary, with regrowth beginning within weeks after treatment ends. ^[16]

• Persistent hair loss
  Rarely, certain agents (notably taxanes like docetaxel) can cause persistent or permanent chemotherapy‑induced alopecia, where hair does not fully return after six months. [PM7] Options to promote regrowth may include topical minoxidil, low‑level light therapy (photobiomodulation), or platelet‑rich plasma, although evidence and availability vary. [PM7]

---

Special Cases: EGFR‑Inhibitor–Related Scalp Conditions

• Nonscarring alopecia and hair changes
  EGFR inhibitors may cause hair texture changes or nonscarring alopecia alongside skin rashes, dryness, and nail changes. Dermatology evaluation helps tailor topical or systemic treatments and preserve cancer therapy continuity. [PM26] [PM28]

• Scarring alopecia (folliculitis decalvans)
  Although rare, scarring alopecia has been reported with EGFR inhibitors; early diagnosis and treatment are crucial to prevent permanent hair loss. [PM24]

---

Practical Checklist

• Ask your oncologist which drugs you will receive and the specific alopecia risk for your regimen. ^[1]
• If risk is moderate to high, consider scalp cooling and discuss logistics at your infusion center. ^{[11] [8]}
• Start gentle hair care and protect your scalp from cold and sun during treatment. ^{[4] [5] [6]}
• Plan wigs or head coverings early if desired. ^[13]
• Seek dermatology support for rashes, scalp tenderness, or unusual patterns of hair loss, especially on targeted therapies. [PM26] [PM24]
• If hair does not start to return months after therapy, ask about regrowth treatments and evaluation for persistent alopecia. [PM7]

---

Key Takeaways

• Hair loss in lung cancer is usually treatment‑related, not a symptom of the cancer. ^[1]
• Chemotherapy can cause temporary hair loss, with onset 2–3 weeks after starting; scalp cooling can help reduce it for some regimens. ^{[4] [8]}
• Targeted therapy rarely causes hair loss, and immunotherapy does so infrequently; however, EGFR inhibitors can cause specific scalp and hair issues, sometimes requiring prompt dermatologic care. ^{[2] [3]} [PM26] [PM24]

---

궁금한 점 있으면 언제든 퍼슬리에 물어보세요